Radiometer logo

NICU point-of-care testing solution

Get support in making well-informed treatment decisions with our NICU solution

  • Request info

    Get in touch to learn how the NICU solution supports you in making well-informed treatment decisions

    Contact details

    Workplace details

    By submitting this form, I acknowledge that I have reviewed and understood the data privacy notice.

    All fields must be filled!

  • Download the brochure
    Sign up to access the neonatal intensive care solution brochure.

    Contact Info

    By submitting this form, I acknowledge that I have reviewed and understood the data privacy notice.

    All fields must be filled!

Careful monitoring of the neonate

Neonates born premature may present a range of critical conditions that caregivers need to diagnose, treat and monitor. The care that neonates receive in the first hours and days can have a significant impact on their quality of life. [1,2]

In the short term, the recognition and treatment of critical symptoms can save the neonate’s life. [3]

In the long term, when caregivers provide correct and timely treatment and avoid life-altering complications, this helps contribute to better quality of life. [3]

The rapidly changing conditions of the neonate and undetected oxygen changes can be challenging in the neonatal intensive care unit (NICU). The NICU solution supports you in making diagnostic decisions and in caring for neonates.

Overview of the parameters that you can measure with the Radiometer NICU solution

Our NICU solution supports you in critical decision-making

The possibility to change the course of a preterm neonate's life starts here. By providing you with insight into the neonate's condition, we aim to support you in making well-informed treatment decisions.

The dedicated NICU solution includes:

  • blood gas testing on a very small blood sample

  • continuous non-invasive transcutaneous monitoring of oxygen and carbon dioxide levels

The combination of advanced technologies and an extensive panel of tests gives you access to accurate and real-time information about the neonate’s condition.

Leading the way in caring for fragile patients

The beginnings of Radiometer were rooted in caring for fragile patients. The polio epidemic that swept Europe in 1954 was a crucial turning point in the formation of the company today. Dr. Poul Astrup approached us to support him in developing special equipment to help diagnose children with polio. [1, 2]

Radiometer continues to lead the way in the development of advanced medical devices for fragile patients with the NICU solution.

The combined blood gas and transcutaneous monitoring solution gives you detailed information on the neonate’s respiratory and metabolic status.


ABL90 FLEX PLUS blood gas analyzer

  • 19 critical parameters on only 65 microliters of blood with creatinine and urea

  • Dedicated 45 microliter Micromode measurement for capillary tube samples*

  • Results in 35-60 seconds depending on mode

    *Excluding creatinine and urea

TCM5 FLEX transcutaneous monitor

  • System defined limits of site time vs. temperature help reduce the risk of harm from the heated sensor

  • Real-time trending complements blood gas sampling

  • Auto calibration keeps the sensor ready in the background

CLINITUBES capillary tubes

  • Designed with rounded ends

Partner with the blood gas testing specialists

When you choose Radiometer, you tap into more than fifty years of experience in blood gas testing. You get access to services, support and knowledge: 

Scientific Insights from Radiometer

Discover new clinical insights about transcutaneous monitoring.

Read the latest Scientific Insights paper from Radiometer here.


1. Ancel PY et al. Survival and morbidity of preterm children born at 22 through 34 weeks' gestation in France in 2011: results of the EPIPAGE-2 cohort study. JAMA Pediatr. 2015; 169, 3: 230-238.

2. Fanaroff AA et al. NICHD Neonatal Research Network. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol. 2007; 196, 2: 147.e

3. BOOST II United Kingdom Collaborative Group; BOOST II Australia Collaborative Group; BOOST II New Zealand Collaborative Group, Stenson BJ, Tarnow-Mordi WO. Oxygen saturation and outcomes in preterm Infants. N Engl J Med 2013; 368, 22:2094-2104.

4. Holbek CC. 25 years of RADIOMETER blood gas analyzers. Aspects of biomedical engineering in Denmark 1998: 133–41.

5. Severinghaus J et al. Blood gas analysis and critical care medicine. AM J Respir Crit Care Med 1998; 157: S114-S122.

MAPSSS-000056 R3

Cookies are used on this website

Use of cookies
Confirm your account with Radiometer

Please enter a valid email

By submitting your e-mail you agree to the data policy notice
Radiometer is using Microsoft Azure Active Directory to authenticate customer access. If you are already registered you will be taken to Microsoft AD to sign in using your Microsoft AD credentials.
You are already registered
Radiometer is using Microsoft Azure AD to authenticate customer access. If you are already registered you will be taken to AZURE to sign in using your AZURE credentials.
Thank you

We will be sending an e-mail invitation to you shortly to sign in using Microsoft Azure AD.

Radiometer is using Microsoft Azure AD to authenticate customer access.

It seems that your e-mail is not registered with us

Radiometer is using Microsoft Azure AD to authenticate customer access. If your e-mail is not registered with us please click CONTINUE and we will guide you through the sign-in process.
We have previously sent an invitation by e-mail

Please click "Get started" in the e-mail to complete the registration process

Radiometer is using Microsoft Azure AD to authenticate customer access.

We were not able to process your request due to a communication error


It seems this account has not been given access to the portal

Radiometer is using Microsoft AZURE Active Directory to authenticate users

Radiometer uses Azure AD to provide our customers and partners secure access to documents, resources, and other services on our customer portal.

If your organization is already using Azure AD you can use the same credentials to access Radiometer's customer portal.

Key benefits

  • Allow the use of existing Active Directory credentials
  • Single-sign on experience
  • Use same credentials to access future services

Request access

You will receive an invitation to access our services via e-mail when your request has been approved.

When you accept the invitation, and your organization is already using AZURE AD, you can use the same credentials to access Radiometer's customer portal. Otherwise, a one-time password will be sent via e-mail to sign in.

Effective Date January 20th, 2023 (last updated January 20th, 2023)


Radiometer values your privacy and the protection of your personal data. This policy (“Policy”) explains how Radiometer its affiliates, subsidiaries or related companies, a full list of which can be located here (together, “Radiometer”, “our”, “us”, or “we”), collects, uses, shares, transfers and processes data collected from or about you.

Personal Data” is any information that can be used to directly or indirectly identify an individual or that can be reasonably expected to link to an individual. This can include items such as name, address, telephone number, credit card details, email address, ID number, Internet Protocol (“IP”) address of an electronic device used by an individual, or other identifying code (even absent of other identifying information). Statistical and non-identifiable metric data are not considered Personal Data.

The Radiometer subsidiary, affiliate or related company with which you interact is, where applicable, the data controller (or equivalent under applicable law) responsible for the processing of your Personal Data. You can find a list of the relevant legal entities that act as data controllers in Appendix 1 to this Policy.


This Policy describes the types of Personal Data that we may collect, process or disclose about you and how you may govern this processing by exercising applicable legal rights. This Policy applies to both online and offline information collection, including your use of websites or subdomains operated by us, any mobile applications, when we provide products and/or services to you or notify you about prospective items of interest and in other situations where you interact with us in-person, by telephone or by mail where this Policy is posted or referenced.

There may be occasion where you have been provided with a circumstance-specific privacy notice that is separate from this policy, such as privacy notices for specific activities such as Recruitment. To the extent you were provided with a different notice, those notices apply and govern our interactions with you. If you provide Personal Data about parties other than yourself, you are responsible for ensuring their knowledge of how we will process their personal data, and, where applicable, obtaining any necessary consents required in advance.

We are committed to processing Personal Data in accordance with applicable laws. Please note that if you do not wish to provide your Personal Data to us, some products and/or services may become unavailable to you. Your use of any or all these platforms indicates you have been notified of our collection, use, transfer, and disclosure of your information as described in this Policy to the extent permitted by applicable law.

Read more